Welcome!

News Feed Item

Agile Therapeutics Appoints Dr. Elizabeth Ijeoma Onyemelukwe Garner as Chief Medical Officer

PRINCETON, N.J., Jan. 8, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., announced today the appointment of Elizabeth Ijeoma Onyemelukwe Garner, M.D., M.P.H., as Chief Medical Officer effective January 6, 2014.  Dr. Garner will be a member of Agile's executive management team and will lead the clinical research, drug safety and medical affairs teams in the clinical development of the Company's product pipeline.

"Elizabeth has prominent expertise in women's health and significant clinical development experience in the pharmaceutical industry and we are very pleased to welcome her as a member of our executive management team," said Al Altomari, Chief Executive Officer of Agile Therapeutics. "Her strong and highly relevant experience overseeing successful clinical trial programs and regulatory approval is the precise expertise we seek to advance our development programs of our innovative hormonal contraceptive treatment option and to drive the long-term growth."

Most recently, Dr. Garner served as Vice President, Women's Health and Preventive Care at Myriad Genetics Laboratories, and managed the women's health clinical research, publication, and Key Opinion Leader (KOL) development program, provided medical and scientific input to the company's marketing and new product strategies, and served as the company's media spokesperson.  Prior to joining Myriad Genetics, she was Senior Director at Abbott (now AbbVie) where she managed the global Phase III clinical development program in endometriosis.  From 2007 to 2011, Dr. Garner served as Director, Vaccines Clinical Research at Merck Research Laboratories where she was a key clinical development leader for the human papillomavirus vaccine program and was instrumental in achieving successful outcomes on important supplemental submissions to the Food and Drug Administration.

"I am extremely pleased to be joining Agile Therapeutics and I look forward to building upon the significant momentum of the clinical development programs and bringing them to a successful outcome," said Dr. Elizabeth Garner. "I look forward to helping the company fulfill its goal of offering women a safe and convenient hormonal option that represents real innovation and fills a critical void in women's contraception."

Prior to entering the pharmaceutical industry, Dr. Garner had several years of experience in academic clinical practice, research and teaching at Harvard Medical School.  She received joint M.D. and M.P.H degrees from Harvard Medical School and the School of Public Health.  Dr. Garner did her residency in obstetrics and gynecology at Brigham and Women's/Massachusetts General Hospitals, her subspecialty fellowship in gynecologic oncology at Brigham and Women's and the Dana Farber Cancer Institute, and received board certification in both general Obstetrics and Gynecology and Gynecologic Oncology.  Dr. Garner is an author on numerous scientific papers published in peer-reviewed journals and has received many awards and honors over the course of her career.

About Agile Therapeutics
Agile Therapeutics is a specialty pharmaceutical company focused on women's health that is currently developing innovative contraceptive products based on Agile's proprietary and patented transdermal technology called Skinfusion®. Skinfusion consists of both an active and a peripheral adhesive system designed to allow stable drug delivery and dependable adhesion over seven days. The Company's lead investigational product, Twirla(AG200-15), is a once-weekly contraceptive patch designed to provide convenience and compliance that is currently in late stage clinical development. Agile has an additional pipeline of product candidates consisting of innovative contraceptive patch regimens and a progestin-only contraceptive patch (AG890) that utilize Skinfusion.  For more information, please visit http://www.agiletherapeutics.com.

Forward Looking Statements
Certain matters discussed in this press release are "forward-looking statements".  We may, in some cases, use terms such as "predicts," "believes," "potential," "continue," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "will," "should" or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements.  In particular, the Company's statements regarding trends and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the success, timing and cost of our ongoing clinical trials and anticipated clinical trials for our current product candidates, including statements regarding the timing of initiation and completion of the trials; the timing of and our ability to obtain and maintain U.S. Food and Drug Administration or other regulatory authority approval of, or other action with respect, to our product candidates; the Company's ability to successfully defend its intellectual property or obtain the necessary licenses at a cost acceptable to the Company, if at all; the successful implementation of the Company's research and development programs and collaborations; the success of the Company's license agreements; the acceptance by the market of the Company's products; and other factors, including general economic conditions and regulatory developments, not within the Company's control.  The factors discussed herein could cause actual results and developments to be materially different from those expressed in or implied by such statements.  The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance.

SOURCE Agile Therapeutics, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With the proliferation of both SQL and NoSQL databases, organizations can now target specific fit-for-purpose database tools for their different application needs regarding scalability, ease of use, ACID support, etc. Platform as a Service offerings make this even easier now, enabling developers to roll out their own database infrastructure in minutes with minimal management overhead. However, this same amount of flexibility also comes with the challenges of picking the right tool, on the right ...
With over 720 million Internet users and 40–50% CAGR, the Chinese Cloud Computing market has been booming. When talking about cloud computing, what are the Chinese users of cloud thinking about? What is the most powerful force that can push them to make the buying decision? How to tap into them? In his session at 18th Cloud Expo, Yu Hao, CEO and co-founder of SpeedyCloud, answered these questions and discussed the results of SpeedyCloud’s survey.
Organizations planning enterprise data center consolidation and modernization projects are faced with a challenging, costly reality. Requirements to deploy modern, cloud-native applications simultaneously with traditional client/server applications are almost impossible to achieve with hardware-centric enterprise infrastructure. Compute and network infrastructure are fast moving down a software-defined path, but storage has been a laggard. Until now.
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
"This week we're really focusing on scalability, asset preservation and how do you back up to the cloud and in the cloud with object storage, which is really a new way of attacking dealing with your file, your blocked data, where you put it and how you access it," stated Jeff Greenwald, Senior Director of Market Development at HGST, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
The 19th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportuni...
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and shared the must-have mindsets for removing complexity from the develo...
“We're a global managed hosting provider. Our core customer set is a U.S.-based customer that is looking to go global,” explained Adam Rogers, Managing Director at ANEXIA, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Basho Technologies has announced the latest release of Basho Riak TS, version 1.3. Riak TS is an enterprise-grade NoSQL database optimized for Internet of Things (IoT). The open source version enables developers to download the software for free and use it in production as well as make contributions to the code and develop applications around Riak TS. Enhancements to Riak TS make it quick, easy and cost-effective to spin up an instance to test new ideas and build IoT applications. In addition to...
Predictive analytics tools monitor, report, and troubleshoot in order to make proactive decisions about the health, performance, and utilization of storage. Most enterprises combine cloud and on-premise storage, resulting in blended environments of physical, virtual, cloud, and other platforms, which justifies more sophisticated storage analytics. In his session at 18th Cloud Expo, Peter McCallum, Vice President of Datacenter Solutions at FalconStor, discussed using predictive analytics to mon...
IoT is rapidly changing the way enterprises are using data to improve business decision-making. In order to derive business value, organizations must unlock insights from the data gathered and then act on these. In their session at @ThingsExpo, Eric Hoffman, Vice President at EastBanc Technologies, and Peter Shashkin, Head of Development Department at EastBanc Technologies, discussed how one organization leveraged IoT, cloud technology and data analysis to improve customer experiences and effi...
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with the 19th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world and ThingsExpo Silicon Valley Call for Papers is now open.
"We've discovered that after shows 80% if leads that people get, 80% of the conversations end up on the show floor, meaning people forget about it, people forget who they talk to, people forget that there are actual business opportunities to be had here so we try to help out and keep the conversations going," explained Jeff Mesnik, Founder and President of ContentMX, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Isomorphic Software will exhibit at DevOps Summit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Isomorphic Software provides the SmartClient HTML5/AJAX platform, the most advanced technology for building rich, cutting-edge enterprise web applications for desktop and mobile. SmartClient combines the productivity and performance of traditional desktop software with the simp...
"When you think about the data center today, there's constant evolution, The evolution of the data center and the needs of the consumer of technology change, and they change constantly," stated Matt Kalmenson, VP of Sales, Service and Cloud Providers at Veeam Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.